연구동향 분석
박사

Versatile application of the CRISPR-Cas system to various organisms

유지현 2018년

논문상세정보
인용/피인용
' Versatile application of the CRISPR-Cas system to various organisms' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 생활과학
  • CRISPR-Cas
  • cancer diagnosis
  • ctdna
  • dnademethylation
  • genome engineering
  • ribonucleoprotein
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,551 0

0.0%

' Versatile application of the CRISPR-Cas system to various organisms' 의 참고문헌

  • Zetsche, B., J. S. Gootenberg, O. O. Abudayyeh, I. M. Slaymaker, K. S. Makarova and P. Essletzbichler. 2015. Cpf1 is a single RNA-guided endonuclease of a class 2 CRISPR-Cas system. Cell. 163: 759-771.
  • Yu, J., K. Baek, E. Jin and S. Bae. 2017. DNA-free Genome Editing of Chlamydomonas reinhardtii Using CRISPR and Subsequent Mutant Analysis. Bio-protocol. 7, (11) DOI: 10.21769/BioProtoc.2352
  • Yamano, T., H. Nishimasu, B. Zetsche, H. Hirano, I. M. Slaymaker and Y. Li. 2016. Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell. 165: 949-962.
  • Xu, X., Y. Tao, X. Gao, L. Zhang, X. Li, W. Zou, K. Ruan, F. Wang, G. L. Xu and R. Hu. 2016. A CRISPR-based approach for targeted DNA demethylation. Cell Discov. 2: 16009.
  • Xu, X., W. B. Wei, B. Li, F. Gao, Z. Zhang and J. B. Jonas. 2014. Oncogenic GNAQ and GNA11 mutations in uveal melanoma in Chinese. P Lo S One. 9: e109699.
  • Wu, Y., D. Liang, Y. Wang, M. Bai, W. Tang and S. Bao. 2013. Correction of a genetic disease in mouse via use of CRISPRCas9. Cell Stem Cell. 13: 659-662.
  • Wu, H. and Y. Zhang. 2014. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell. 156(1- 2): 45-68.
  • Wood, L. D., D. W. Parsons, S. Jones, J. Lin, T. Sjoblom and R. J. Leary. 2007. The genomic landscapes of human breast and colorectal cancers. Science. 318: 1108-1113.
  • Vojta, A., P. Dobrinic, V. Tadic, L. Bockor, P. Korac, B. Julg, M. Klasic and V. Zoldos. 2016. Repurposing the CRISPR-Cas9 system for targeted DNA methylation. Nucleic Acids Res. 44(12): 5615-5628.
  • Vogelstein, B., N. Papadopoulos, V. E. Velculescu, S. B. Zhou, L. A. Diaz and K. W. Kinzler. 2013. Cancer genome landscapes. Science. 339: 1546-1558.
  • Sorber, L., K. Zwaenepoel, V. Deschoolmeester, P. E. Y. Van Schil, J. Van Meerbeeck and F. Lardon. 2017. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients. Lung Cancer. 107: 100-107.
  • Soppe, W. J., S. E. Jacobsen, C. Alonso-Blanco, J. P. Jackson, T. Kakutani, M. Koornneef and A. J. Peeters. 2000. The late flowering phenotype of fwa mutants is caused by gain-offunction epigenetic alleles of a homeodomain gene. Mol Cell. 6(4): 791-802.
  • Song, C., Y. Liu, R. Fontana, A. Makrigiorgos, H. Mamon and M. H. Kulke. 2016. Elimination of unaltered DNA in mixed clinical samples via nuclease-assisted minor-allele enrichment. Nucleic Acids Res. 44: e146.
  • Sizova, I., A. Greiner, M. Awasthi, S. Kateriya and P. Hegemann. 2013. Nuclear gene targeting in Chlamydomonas using engineered zinc-finger nucleases. Plant J. 73(5): 873-882.
  • Schwarzenbach, H., D. S. B. Hoon and K. Pantel. 2011. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 11: 426-437.
  • Rudin, N. and J. E. Haber. 1988. Efficient repair of HO-induced chromosomal breaks in Saccharomyces cerevisiae by recombination between flanking homologous sequences. Mol Cell Biol. 8(9): 3918-3928.
  • Park, J., K. Lim, J. S. Kim and S. Bae. 2017. Cas-analyzer: an online tool for assessing genome editing results using NGS data. Bioinformatics. 33: 286-288.
  • Park, J. Y., L. J. Kricka and P. Fortina. 2013. Next-generation sequencing in the clinic. Nat Biotechnol. 31: 990-992.
  • Park, J. T., N. Johnson, S. Liu, M. Levesque, Y. J. Wang and H. Ho. 2015. Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: a comprehensive survey. Oncogene. 34: 2801-2806.
  • Ouyang, M., X. Li, J. Ma, W. Chi, J. Xiao, M. Zou, F. Chen, C. Lu and L. Zhang. 2011. LTD is a protein required for sorting lightharvesting chlorophyll-binding proteins to the chloroplast SRP pathway. Nat Commun. 2: 277.
  • Nu ez, J. K., P. J. Kranzusch, J. Noeske, A. V. Wright, C. W. Davies and J. A. Doudna. 2014. Cas1–Cas2 complex formation mediates spacer acquisition during CRISPR–Cas adaptive immunity. Nature Structural &Amp; Molecular Biology. 21: 528.
  • Nishimasu, H., F. A. Ran, Patrick D. Hsu, S. Konermann, Soraya I. Shehata, N. Dohmae, R. Ishitani, F. Zhang and O. Nureki. 2014. Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA. Cell. 156(5): 935-949.
  • Newman, A. M., S. V. Bratman, J. To, J. F. Wynne, N. C. Eclov and L. A. Modlin. 2014. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat Med. 20: 548-554.
  • Narayan, A., N. J. Carriero, S. N. Gettinger, J. Kluytenaar, K. R. Kozak and T. I. Yock. 2012. Ultrasensitive measurement of hotspot mutations in tumor DNA in blood using errorsuppressed multiplexed deep sequencing. Cancer Res. 72: 3492-3498.
  • Moscou, M. J. and A. J. Bogdanove. 2009. A simple cipher governs DNA recognition by TAL effectors. Science. 326(5959): 1501.
  • Mok, Y. G., R. Uzawa, J. Lee, G. M. Weiner, B. F. Eichman, R. L. Fischer and J. H. Huh. 2010. Domain structure of the DEMETER 5-methylcytosine DNA glycosylase. Proceedings of the National Academy of Sciences. 107(45): 19225-19230.
  • Marraffini, L. A. 2015. CRISPR-Cas immunity in prokaryotes. Nature. 526(7571): 55-61.
  • Mali, P., L. Yang, K. M. Esvelt, J. Aach, M. Guell, J. E. DiCarlo, J. E. Norville and G. M. Church. 2013. RNA-Guided Human Genome Engineering via Cas9. Science. 339(6121): 823-826.
  • Makarova, K. S., Y. I. Wolf, O. S. Alkhnbashi, F. Costa, S. A. Shah, S. J. Saunders, R. Barrangou, S. J. Brouns, E. Charpentier, D. H. Haft, P. Horvath, S. Moineau, F. J. Mojica, R. M. Terns, M. P. Terns, M. F. White, A. F. Yakunin, R. A. Garrett, J. van der Oost, R. Backofen and E. V. Koonin. 2015. An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol. 13(11): 722-736.
  • Makarova, K. S., N. V. Grishin, S. A. Shabalina, Y. I. Wolf and E. V. Koonin. 2006. A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct. 1: 7.
  • Maeder, M. L., J. F. Angstman, M. E. Richardson, S. J. Linder, V. M. Cascio, S. Q. Tsai, Q. H. Ho, J. D. Sander, D. Reyon, B. E. Bernstein, J. F. Costello, M. F. Wilkinson and J. K. Joung. 2013. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol. 31(12): 1137-1142.
  • Liu, X. S., H. Wu, X. Ji, Y. Stelzer, X. Wu, S. Czauderna, J. Shu, D. Dadon, R. A. Young and R. Jaenisch. 2016. Editing DNA Methylation in the Mammalian Genome. Cell. 167(1): 233- 247 e217.
  • Li, M., F. Diehl, D. Dressman, B. Vogelstein and K. W. Kinzler. 2006. BEAMing up for detection and quantification of rare sequence variants. Nat Methods. 3: 95-97.
  • Lee, S. H. and S. Bae. 2016. Structural and dynamic views of the CRISPR-Cas system at the single-molecule level. Bmb Rep. 49: 201-207.
  • Law, J. A. and S. E. Jacobsen. 2010. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat Rev Genet. 11(3): 204-220.
  • Kruglyak, K. M., E. Lin and F. S. Ong. 2014. Next-generation sequencing in precision oncology: challenges and opportunities. Expert Rev Mol Diagn. 14: 635-637.
  • Koonin, E. V., K. S. Makarova and F. Zhang. 2017. Diversity, classification and evolution of CRISPR-Cas systems. Current Opinion in Microbiology. 37(Supplement C): 67-78.
  • Kinoshita, Y., H. Saze, T. Kinoshita, A. Miura, W. J. Soppe, M. Koornneef and T. Kakutani. 2007. Control of FWA gene silencing in Arabidopsis thaliana by SINE-related direct repeats. Plant J. 49(1): 38-45.
  • Kinde, I., J. Wu, N. Papadopoulos, K. W. Kinzler and B. Vogelstein. 2011. Detection and quantification of rare mutations with massively parallel sequencing. Proc Natl Acad Sci Usa. 108: 9530-9535.
  • Kim, Y. G., J. Cha and S. Chandrasegaran. 1996. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc Natl Acad Sci U S A. 93(3): 1156-1160.
  • Kim, J. S. 2016. Genome editing comes of age. Nat Protoc. 11(9): 1573-1578.
  • Kim, J. M., D. Kim, S. Kim and J. S. Kim. 2014. Genotyping with CRISPR-Cas-derived RNA-guided endonucleases. Nat Commun. 5: 3157.
  • Kim, H. and J. S. Kim. 2014. A guide to genome engineering with programmable nucleases. Nat Rev Genet. 15: 321-334.
  • Kim, D., J. Kim, J. K. Hur, K. W. Been, S. H. Yoon and J. S. Kim. 2016. Genome-wide analysis reveals specificities of Cpf1 endonucleases in human cells. Nat Biotechnol. 34: 863-868.
  • Jinek, M., K. Chylinski, I. Fonfara, M. Hauer, J. A. Doudna and E. Charpentier. 2012. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity. Science. 337: 816-821.
  • Jinek, M., F. Jiang, D. W. Taylor, S. H. Sternberg, E. Kaya, E. Ma, C. Anders, M. Hauer, K. Zhou, S. Lin, M. Kaplan, A. T. Iavarone, E. Charpentier, E. Nogales and J. A. Doudna. 2014. Structures of Cas9 endonucleases reveal RNA-mediated conformational activation. Science. 343(6176): 1247997.
  • Jinek, M., A. East, A. Cheng, S. Lin, E. Ma and J. Doudna. 2013. RNA-programmed genome editing in human cells. Elife. 2: e00471.
  • Jiang, W., A. J. Brueggeman, K. M. Horken, T. M. Plucinak and D. P. Weeks. 2014. Successful transient expression of Cas9 and single guide RNA genes in Chlamydomonas reinhardtii. Eukaryot Cell. 13(11): 1465-1469.
  • Ikeda, Y., Y. Kobayashi, A. Yamaguchi, M. Abe and T. Araki. 2007. Molecular basis of late-flowering phenotype caused by dominant epi-alleles of the FWA locus in Arabidopsis. Plant Cell Physiol. 48(2): 205-220.
  • Hsu, P. D., E. S. Lander and F. Zhang. 2014. Development and applications of CRISPR-Cas9 for genome engineering. Cell. 157(6): 1262-1278.
  • Hilton, I. B., A. M. D'Ippolito, C. M. Vockley, P. I. Thakore, G. E. Crawford, T. E. Reddy and C. A. Gersbach. 2015. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nat Biotechnol. 33(5): 510-517.
  • Heitzer, E., P. Ulz and J. B. Geigl. 2015. Circulating tumor DNA as a liquid biopsy for cancer. Clin Chem. 61: 112-123.
  • Harris, E. H. 2001. CHLAMYDOMONAS AS A MODEL ORGANISM. Annu Rev Plant Physiol Plant Mol Biol. 52: 363-406.
  • Gehring, M., J. H. Huh, T. F. Hsieh, J. Penterman, Y. Choi, J. J. Harada, R. B. Goldberg and R. L. Fischer. 2006. DEMETER DNA glycosylase establishes MEDEA polycomb gene selfimprinting by allele-specific demethylation. Cell. 124(3): 495-506.
  • Garneau, J. E., M.- . Dupuis, M. Villion, D. A. Romero, R. Barrangou, P. Boyaval, C. Fremaux, P. Horvath, A. H. Magad n and S. Moineau. 2010. The CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA. Nature. 468: 67.
  • Gao, H., D. A. Wright, T. Li, Y. Wang, K. Horken, D. P. Weeks, B. Yang and M. H. Spalding. 2014. TALE activation of endogenous genes in Chlamydomonas reinhardtii. Algal Research. 5(Supplement C): 52-60.
  • Fu, W., A. Chaiboonchoe, B. Khraiwesh, D. R. Nelson, D. Al-Khairy, A. Mystikou, A. Alzahmi and K. Salehi-Ashtiani. 2016. Algal Cell Factories: Approaches, Applications, and Potentials. Mar Drugs. 14(12).
  • Friedland, A. E., Y. B. Tzur, K. M. Esvelt, M. P. Colaiacovo, G. M. Church and J. A. Calarco. 2013. Heritable genome editing in C. elegans via a CRISPR-Cas9 system. Nat Methods. 10: 741- 743.
  • Freidin, M. B., D. V. Freydina, M. Leung, A. M. Fernandez, A. G. Nicholson and E. Lim. 2015. Circulating tumor DNA outperforms circulating tumor cells for KRAS mutation detection in thoracic malignancies. Clin Chem. 61: 1299-1304.
  • Forshew, T., M. Murtaza, C. Parkinson, D. Gale, D. W. Tsui and F. Kaper. 2012. Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med. 4: 136ra168.
  • Forbes, S. A., G. Tang, N. Bindal, S. Bamford, E. Dawson and C. Cole. 2010. COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res. 38: D652-D657.
  • Deltcheva, E., K. Chylinski, C. M. Sharma, K. Gonzales, Y. Chao, Z. A. Pirzada, M. R. Eckert, J. Vogel and E. Charpentier. 2011. CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III. Nature. 471: 602.
  • De Mattos-Arruda, L. and C. Caldas. 2016. Cell-free circulating tumour DNA as a liquid biopsy in breast cancer. Mol Oncol. 10: 464-474.
  • Dawson, S. J., D. W. Tsui, M. Murtaza, H. Biggs, O. M. Rueda and S. F. Chin. 2013. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med. 368: 1199-1209.
  • Dagdas, Y. S., J. S. Chen, S. H. Sternberg, J. A. Doudna and A. Yildiz. 2017. A conformational checkpoint between DNA binding and cleavage by CRISPR-Cas9. Sci Adv. 3(8).
  • Daboussi, F., S. Leduc, A. Mar chal, G. Dubois, V. Guyot, C. Perez- Michaut, A. Amato, A. Falciatore, A. Juillerat, M. Beurdeley, D. F. Voytas, L. Cavarec and P. Duchateau. 2014. Genome engineering empowers the diatom Phaeodactylum tricornutum for biotechnology. Nature Communications. 5: 3831.
  • Cox, D. B. T., J. S. Gootenberg, O. O. Abudayyeh, B. Franklin, M. J. Kellner, J. Joung and F. Zhang. 2017. RNA editing with CRISPR-Cas13. Science.
  • Cong, L., F. A. Ran, D. Cox, S. Lin, R. Barretto, N. Habib, P. D. Hsu, X. Wu, W. Jiang, L. A. Marraffini and F. Zhang. 2013. Multiplex Genome Engineering Using CRISPR/Cas Systems. Science.
  • Choudhury, S. R., Y. Cui, K. Lubecka, B. Stefanska and J. Irudayaraj. 2016. CRISPR-dCas9 mediated TET1 targeting for selective DNA demethylation at BRCA1 promoter. Oncotarget. 7(29): 46545-46556.
  • Choi, Y., M. Gehring, L. Johnson, M. Hannon, J. J. Harada, R. B. Goldberg, S. E. Jacobsen and R. L. Fischer. 2002. DEMETER, a DNA glycosylase domain protein, is required for endosperm gene imprinting and seed viability in arabidopsis. Cell. 110(1): 33-42.
  • Cho, S. W., S. Kim, Y. Kim, J. Kweon, H. S. Kim and S. Bae. 2014. Analysis of off-target effects of CRISPR/Cas-derived RNAguided endonucleases and nickases. Genome Res. 24: 132- 141.
  • Cho, S. W., S. Kim, J. M. Kim and J.-S. Kim. 2013. Targeted genome engineering in human cells with the Cas9 RNAguided endonuclease. Nature Biotechnology. 31: 230.
  • Cheng, F. F., L. Su and C. Qian. 2016. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer. Oncotarget. 7: 48832-48841.
  • Chen, H., H. G. Kazemier, M. L. de Groote, M. H. Ruiters, G. L. Xu and M. G. Rots. 2014. Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter. Nucleic Acids Res. 42(3): 1563-1574.
  • Chang-Hao Tsao, S., J. Weiss, C. Hudson, C. Christophi, J. Cebon and A. Behren. 2015. Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations. Sci Rep. 5: 11198.
  • Chang, N., C. Sun, L. Gao, D. Zhu, X. Xu and X. Zhu. 2013. Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res. 23: 465-472.
  • Chan, K. C., P. Jiang, Y. W. Zheng, G. J. Liao, H. Sun and J. Wong. 2013. Cancer genome scanning in plasma: detection of tumor-associated copy number aberrations, singlenucleotide variants, and tumoral heterogeneity by massively parallel sequencing. Clin Chem. 59: 211-224.
  • Ceccaldi, R., B. Rondinelli and A. D. D’Andrea. 2015. Repair Pathway Choices and Consequences at the Double-Strand Break. Trends in Cell Biology. 26(1): 52-64.
  • Boch, J., H. Scholze, S. Schornack, A. Landgraf, S. Hahn, S. Kay, T. Lahaye, A. Nickstadt and U. Bonas. 2009. Breaking the code of DNA binding specificity of TAL-type III effectors. Science. 326(5959): 1509-1512.
  • Bettegowda, C., M. Sausen, R. J. Leary, I. Kinde, Y. Wang and N. Agrawal. 2014. Detection of circulating tumor DNA in early and late-stage human malignancies. Sci Transl Med. 6: 224ra224.
  • Baek, K., D. H. Kim, J. Jeong, S. J. Sim, A. Melis and J. S. Kim. 2016. DNA-free two-gene knockout in Chlamydomonas reinhardtii via CRISPR-Cas9 ribonucleoproteins. Sci Rep. 6: 30620.
  • Bae, S., J. Park and J. S. Kim. 2014. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics. 30(10): 1473-1475.
  • Anders, C., O. Niewoehner, A. Duerst and M. Jinek. 2014. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature. 513: 569.
  • Anders, C., O. Niewoehner, A. Duerst and M. Jinek. 2014. Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease. Nature. 513: 569-573.
  • Alix-Panabieres, C., H. Schwarzenbach and K. Pantel. 2012. Circulating tumor cells and circulating tumor DNA. Annu Rev Med. 63: 199-215.